Yao G - Search Results

1

Virologic, serologic, and biochemical outcomes through 2 years of treatment with entecavir and lamivudine in nucleoside-naïve Chinese patients with chronic hepatitis B: a randomized, multicenter study.

Yao G, Chen C, Lu W, Ren H, Tan D, Wang Y, Xu D, Liu J, Xu D, Llamoso C. Yao G, et al. Hepatol Int. 2008 Dec;2(4):486-93. doi: 10.1007/s12072-008-9088-8. Epub 2008 Aug 30. Hepatol Int. 2008. PMID: 19669324 Free PMC article.

2

[A double-blind, double-dummy, randomized, controlled study of entecavir versus lamivudine for treatment of chronic hepatitis B].

Yao GB, Zhu M, Wang YM, Xu DZ, Tan DM, Chen CW, Hou JL. Yao GB, et al. Zhonghua Nei Ke Za Zhi. 2006 Nov;45(11):891-5. Zhonghua Nei Ke Za Zhi. 2006. PMID: 17313873 Clinical Trial. Chinese.

3

[Results of 3 years of continuous entecavir treatment in nucleos(t)ide-naive chronic hepatitis B patients].

Yao GB, Ren H, Xu DZ, Zhou XQ, Jia JD, Wang YM, Chen CW. Yao GB, et al. Zhonghua Gan Zang Bing Za Zhi. 2009 Dec;17(12):881-6. Zhonghua Gan Zang Bing Za Zhi. 2009. PMID: 20038326 Clinical Trial. Chinese.

4

Entecavir for the treatment of lamivudine-refractory chronic hepatitis B patients in China.

Yao G, Zhou X, Xu D, Wang B, Ren H, Liu J, Xu D, Macdonald L. Yao G, et al. Hepatol Int. 2007 Sep;1(3):373-81. doi: 10.1007/s12072-007-9016-3. Epub 2007 Oct 4. Hepatol Int. 2007. PMID: 19669332 Free PMC article.

5

Efficacy and safety of entecavir compared to lamivudine in nucleoside-naïve patients with chronic hepatitis B: a randomized double-blind trial in China.

Yao G, Chen C, Lu W, Ren H, Tan D, Wang Y, Xu D, Jiang Z, Liu J, Xu D, Macdonald L; AI463023 Study Group. Yao G, et al. Hepatol Int. 2008 Mar;2(1):136. doi: 10.1007/s12072-007-9043-0. Hepatol Int. 2008. PMID: 19669291 Free PMC article. No abstract available.

6

Efficacy and safety of entecavir compared to lamivudine in nucleoside-naïve patients with chronic hepatitis B: a randomized double-blind trial in China.

Yao G, Chen C, Lu W, Ren H, Tan D, Wang Y, Xu D, Jiang Z, Liu J, Xu D, Macdonald L; AI463023 Study Group. Yao G, et al. Hepatol Int. 2007 Sep;1(3):365-72. doi: 10.1007/s12072-007-9009-2. Epub 2007 Jul 31. Hepatol Int. 2007. PMID: 19669331 Free PMC article.

7

Virological, serological and biochemical outcomes through 3 years of entecavir treatment in nucleoside-naive Chinese chronic hepatitis B patients.

Yao GB, Ren H, Xu DZ, Zhou XQ, Jia JD, Wang YM, Chen CW. Yao GB, et al. J Viral Hepat. 2010 Mar;17 Suppl 1:51-8. doi: 10.1111/j.1365-2893.2010.01271.x. J Viral Hepat. 2010. PMID: 20586934 Clinical Trial.

8

A multicenter, randomized, controlled trial of interferon alfacon-1 compared with alpha-2a-interferon in Chinese patients with chronic hepatitis C virus infection.

Yao GB, Fu XX, Tian GS, Xu DZ, Hao LJ, Huangfu YS, Su CX. Yao GB, et al. J Gastroenterol Hepatol. 2000 Oct;15(10):1165-70. doi: 10.1046/j.1440-1746.2000.02307.x. J Gastroenterol Hepatol. 2000. PMID: 11106097 Clinical Trial.

9

Long-term efficacy of recombinant interferon alpha 2a in the treatment of chronic hepatitis C: a randomized prospective study comparing two dose schedules in Chinese patients.

Yao G, Ji Y, Yang M, Xu D, Gao J, Wu X, Zhang Q, Hu D. Yao G, et al. Chin Med J (Engl). 1998 Oct;111(10):922-6. Chin Med J (Engl). 1998. PMID: 11189241 Clinical Trial.

10

[Efficacy and safety in chronic hepatitis B adolescent patients with lamivudine therapy].

Lu WL, Xie DY, Yao JL, Yao GB, Cui ZY, Zhang DF, Wu L. Lu WL, et al. Zhonghua Gan Zang Bing Za Zhi. 2004 Jul;12(7):429-31. Zhonghua Gan Zang Bing Za Zhi. 2004. PMID: 15268810 Clinical Trial. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,647 results

Search Page

Filters